BP heads into its Q1 2026 earnings release with the analyst community having turned notably more positive over the past month.
The most striking recent move came from Scotiabank, where analyst Paul Cheng raised his target from $41 to $58 on April 22 while keeping a Sector Outperform rating — one of the most aggressive upward revisions in the analyst pack. UBS upgraded BP to Buy from Neutral on April 15, adding fresh institutional weight to the bullish side. Wells Fargo lifted its target to $54 from $39 on April 9, maintaining Equal-Weight. The overall direction is clear: multiple desks have repriced their targets sharply higher into this print, even if some remain on the fence about rating. The stock itself has been flat over the past month at $46.35, meaning the upward target revisions have arrived against a backdrop of price consolidation rather than a runaway rally.
The bull case rests on valuation and a re-rating story. BP's EV/EBITDA has compressed over 30 days — down roughly 2.3x — and now sits below 5x on a trailing basis, a level that looks cheap against integrated oil peers. Net debt relative to EBITDA is less than 0.8x, a reasonably conservative leverage profile. Bears, however, can point to a P/E that still looks elevated when measured against the most recent quarterly net income, and to a short-score ranking in the 92nd percentile — a signal that short-side conviction, while not extreme in absolute terms, is high relative to the broader market. Short interest on the NYSE-listed ADR has climbed 24% over the past month to roughly 10.4 million shares, a meaningful build even if float-adjusted levels remain modest.
The lending market for BP borrows is extremely loose. Availability is ample, and borrow costs are negligible — the cost to borrow has oscillated wildly over recent weeks but settled near 0.14% as of April 27, well below the elevated prints seen in mid-April. Options positioning is slightly more defensive than usual; the put/call ratio of 0.53 is about one standard deviation above its 20-day average, but it is nowhere near the 52-week high of 0.72. That says caution, not alarm. Two executive vice presidents sold a combined $1.06 million in shares in March, a mild headwind to the bullish narrative, though the amounts are too small to read as a strong signal.
Tuesday's print will test whether BP can deliver quarterly numbers that begin to close the gap between where the stock trades and the newly elevated analyst targets — and whether the margin profile holds up in an environment of softer oil prices.
See the live data behind this article on ORTEX.
Open BP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
